Literature DB >> 2346285

c-myc Oncogene expression in colorectal cancer: its use in prognosis and role in colorectal carcinogenesis.

H S Goh1, T W Soong, Y S Lee, J Ho, C R Goh.   

Abstract

Expression of the c-myc oncogene was studied in 35 cases of colorectal cancer. Elevated expression was found in 46% (16/35) of cases. This elevated c-myc expression was not significantly correlated with tumour stage, tumour size, tumour differentiation or carcinoembryonic antigen gene expression, demonstrating that it is not a useful prognostic indicator in colorectal cancer. The role of c-myc in colorectal carcinogenesis is discussed in the light of these findings and of the recent advances in molecular biology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346285

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  3 in total

1.  Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors.

Authors:  J L Yang; K T Ow; P J Russell; J M Ham; P J Crowe
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

2.  REGγ is associated with multiple oncogenic pathways in human cancers.

Authors:  Jing He; Long Cui; Yu Zeng; Guangqiang Wang; Ping Zhou; Yuanyuan Yang; Lei Ji; Yanyan Zhao; Jiwu Chen; Zhuo Wang; Tieliu Shi; Pei Zhang; Rui Chen; Xiaotao Li
Journal:  BMC Cancer       Date:  2012-02-23       Impact factor: 4.430

3.  Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer.

Authors:  Natalia Mastrogamvraki; Apostolos Zaravinos
Journal:  NPJ Syst Biol Appl       Date:  2020-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.